McNeil Motrin IB/Advil Comparison Is Substantiated, NAD Finds
This article was originally published in The Tan Sheet
Executive Summary
A claim comparing Motrin IB and Advil made by McNeil Consumer Products in free-standing inserts is a substantiated parity claim, the National Advertising Division of the Council of Better Business Bureaus concluded in its April NAD Case Reports. Evidence submitted to NAD by challenger American Home Products, the maker of Advil, was insufficient to show the claim is an unsubstantiated superiority claim.